Amended And Restated Investor Rights Agreement Sample Contracts

Anaptysbio Inc – Amendment No. 1 to Fourth Amended and Restated Investor Rights Agreement (August 7th, 2018)

This Amendment No. 1 to Fourth Amended and Restated Investor Rights Agreement (this "Amendment") is entered into as of May 8, 2018 by the undersigned parties to that certain Fourth Amended and Restated Investor Rights Agreement, dated as of July 13, 2015 (the "Rights Agreement"), by and among AnaptysBio, Inc., a Delaware corporation (the "Company") and the Investors. Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Rights Agreement.

Vaccinex, Inc. – First Amended and Restated Investor Rights Agreement (July 9th, 2018)

This First Amended and Restated Investor Rights Agreement (the Agreement) is made and entered into as of August 22, 2003 among Vaccinex, Inc., a Delaware corporation (the Company), and those persons listed on Schedule A hereto.

Constellation Pharmaceuticals Inc – CONSTELLATION PHARMACEUTICALS, INC. FIFTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT March 22, 2018 (June 22nd, 2018)

This Agreement dated as of March 22, 2018 is entered into by and among Constellation Pharmaceuticals, Inc., a Delaware corporation (the Company), and the individuals and entities listed on Exhibit A attached hereto (the Purchasers).

Crinetics Pharmaceuticals, Inc. – Crinetics Pharmaceuticals, Inc. Amended and Restated Investor Rights Agreement (June 22nd, 2018)

THIS AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (this Agreement) is entered into as of February 9, 2018 by and among CRINETICS PHARMACEUTICALS, INC., a Delaware corporation (the Company), and the investors listed on Exhibit A hereto (collectively referred to hereinafter as the Investors and each individually as an Investor).

M/A-Com Technology Solutions Ho – Third Amendment to the Second Amended and Restated Investor Rights Agreement (June 8th, 2018)
Tricida, Inc. – Tricida, Inc. Amendment No. 1 to the Amended and Restated Investor Rights Agreement (June 4th, 2018)

This Amendment No. 1 to the Amended and Restated Investor Rights Agreement (this Amendment), is made and entered into dated as of February 28, 2018, and amends that certain Amended and Restated Investor Rights Agreement, dated as of November 7, 2017 by and among Tricida, Inc., a Delaware corporation (the Company), and the entities set forth on Exhibit A thereto (the Agreement). Capitalized terms not defined in this Amendment have the meanings set forth in the Agreement.

Tricida, Inc. – Tricida, Inc. Amended and Restated Investor Rights Agreement (June 4th, 2018)

THIS AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the Agreement) is entered into as of the 7th day of November, 2017, by and among TRICIDA, INC., a Delaware corporation (the Company), and the entities listed on EXHIBIT A hereto (each, an Investor and together, the Investors).

Forty Seven, Inc. – Forty Seven, Inc. Amended and Restated Investor Rights Agreement (June 1st, 2018)

THIS AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the Agreement) is entered into as of October 17, 2017, by and among FORTY SEVEN, INC., a Delaware corporation (the Company) and the investors listed on EXHIBIT A hereto, referred to hereinafter as the Investors and each individually as an Investor.

Domo, Inc. – Domo, Inc. Amended and Restated Investor Rights Agreement (June 1st, 2018)

This Amended and Restated Investor Rights Agreement (this "Agreement") is made as of April 13, 2017, by and among Domo, Inc., a Delaware corporation (the "Company"), Joshua G. James (the "Founder"), the individuals and entities set forth on Exhibit A hereto (each, an "Investor", and collectively, the "Investors") and holders of the Company's Class B Common Stock (the "Stockholders") set forth on Exhibit B hereto. Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in Section 1.

Adaptive Insights Inc – Adaptive Insights, Inc. Amended and Restated Investor Rights Agreement (May 17th, 2018)

THIS AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the Agreement) is entered into as of June 22, 2015, by and among ADAPTIVE INSIGHTS, INC., a Delaware corporation (the Company), and the investors listed on Exhibit A hereto, referred to hereinafter as the Investors and each individually as an Investor.

Ares Management Lp – Amended and Restated Investor Rights Agreement by and Among Ares Management, L.P., Ares Management Gp Llc, Ares Owners Holdings L.P., Arec Holdings Ltd., (May 7th, 2018)

This AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (this "Agreement") is entered into as of May 4, 2018 and effective as of March 1, 2018 (the "Effective Date"), by and among (i) Ares Management, L.P, a Delaware limited partnership (the "Issuer"), (ii) Ares Management GP LLC, a Delaware limited partnership ("Ares GP"), (iii) Ares Owners Holdings L.P., a Delaware limited partnership ("Ares LP"), (iv) AREC Holdings Ltd., a Cayman exempted corporation, (v) Blue Spectrum ZA 2015, L.P., a Cayman exempted limited partnership, (vi) Alleghany Insurance Holdings LLC, a Delaware limited liability company ("Alleghany" and, together with AREC, the "Minority Investors") and (vii) each other holder of equity interests in any Company who hereafter delivers a written agreement to be bound by the terms hereof in the form of Exhibit A. Certain capitalized terms used herein are defined in Section 5.1.

Crinetics Pharmaceuticals, Inc. – Crinetics Pharmaceuticals, Inc. Amended and Restated Investor Rights Agreement (May 3rd, 2018)

THIS AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (this Agreement) is entered into as of February 9, 2018 by and among CRINETICS PHARMACEUTICALS, INC., a Delaware corporation (the Company), and the investors listed on Exhibit A hereto (collectively referred to hereinafter as the Investors and each individually as an Investor).

Iterum Therapeutics Ltd – Iterum Therapeutics Limited Amended and Restated Investor Rights Agreement (May 1st, 2018)

THIS AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (this Agreement) is entered into as of May 18, 2017, by and among ITERUM THERAPEUTICS LIMITED, a company incorporated under the laws of Ireland (company number 563531) (the Company) and the investors listed on Exhibit A hereto, referred to hereinafter as the Investors and each individually as an Investor, and each of the shareholders listed on Exhibit B hereto, each of whom is referred to herein as a Key Holder All references to $ and dollar herein shall mean United States dollars.

Constellation Pharmaceuticals Inc – CONSTELLATION PHARMACEUTICALS, INC. FIFTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT March 22, 2018 (April 27th, 2018)

This Agreement dated as of March 22, 2018 is entered into by and among Constellation Pharmaceuticals, Inc., a Delaware corporation (the Company), and the individuals and entities listed on Exhibit A attached hereto (the Purchasers).

Inspire Medical Systems, Inc. – Amendment No. 1 to the Fifth Amended and Restated Investor Rights Agreement (April 23rd, 2018)

This Amendment No. 1 to the Fifth Amended and Restated Investor Rights Agreement (this Amendment) is entered into as of April 20, 2018 by and among Inspire Medical Systems, Inc., a Delaware corporation (the Company), and certain stockholders of the Company party to the Investor Rights Agreement (as defined below) (collectively, the Investors). Capitalized terms used and not defined herein shall have the meaning set forth in the Investor Rights Agreement.

Tricida, Inc. – Tricida, Inc. Amendment No. 1 to the Amended and Restated Investor Rights Agreement (April 16th, 2018)

This Amendment No. 1 to the Amended and Restated Investor Rights Agreement (this Amendment), is made and entered into dated as of February 28, 2018, and amends that certain Amended and Restated Investor Rights Agreement, dated as of November 7, 2017 by and among Tricida, Inc., a Delaware corporation (the Company), and the entities set forth on Exhibit A thereto (the Agreement). Capitalized terms not defined in this Amendment have the meanings set forth in the Agreement.

Tricida, Inc. – Tricida, Inc. Amended and Restated Investor Rights Agreement (April 16th, 2018)

THIS AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the Agreement) is entered into as of the 7th day of November, 2017, by and among TRICIDA, INC., a Delaware corporation (the Company), and the entities listed on EXHIBIT A hereto (each, an Investor and together, the Investors).

Vaccinex, Inc. – First Amended and Restated Investor Rights Agreement (April 13th, 2018)

This First Amended and Restated Investor Rights Agreement (the Agreement) is made and entered into as of August 22, 2003 among Vaccinex, Inc., a Delaware corporation (the Company), and those persons listed on Schedule A hereto.

Stellar Acquisition III Inc. – PHUNWARE, Inc. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT December 18, 2015, as Amended on October 25, 2016 PHUNWARE, Inc. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (April 11th, 2018)

This Amended and Restated Investor Rights Agreement (this "Agreement") is made as of December 18, 2015, as amended on October 25, 2016, by and among Phunware, Inc., a Delaware corporation (the "Company"), and the persons and entities (each, an "Investor" and collectively, the "Investors") listed on Exhibit A hereto. Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in Section 1.

Carbon Black, Inc. – Eighth Amended and Restated Investor Rights Agreement (April 9th, 2018)

THIS EIGHTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the Agreement) is made as of the 30th day of September, 2015, by and among Bit9, Inc., a Delaware corporation (the Company), each of the investors listed on Schedule A hereto (each an Investor and collectively, the Investors, which terms shall also include each person to whom the rights of an Investor are assigned pursuant to Section 6.11 and each person who becomes subject to the provisions hereof pursuant to Section 6.16), each of the key holders listed on Schedule B hereto (each a Key Holder and collectively, the Key Holders, which terms shall also include each person to whom the rights of a Key Holder are assigned pursuant to Section 6.11) and each Carbon Black Stockholder (as defined below).

Forty Seven, Inc. – Forty Seven, Inc. Amended and Restated Investor Rights Agreement (March 23rd, 2018)

THIS AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the Agreement) is entered into as of October 17, 2017, by and among FORTY SEVEN, INC., a Delaware corporation (the Company) and the investors listed on EXHIBIT A hereto, referred to hereinafter as the Investors and each individually as an Investor.

Adaptive Insights Inc – Adaptive Insights, Inc. Amended and Restated Investor Rights Agreement (March 15th, 2018)

THIS AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the Agreement) is entered into as of June 22, 2015, by and among ADAPTIVE INSIGHTS, INC., a Delaware corporation (the Company), and the investors listed on Exhibit A hereto, referred to hereinafter as the Investors and each individually as an Investor.

Akcea Therapeutics, Inc. – Akcea Therapeutics, Inc. Amended and Restated Investor Rights Agreement (March 15th, 2018)

THIS INVESTOR RIGHTS AGREEMENT (this Agreement) is entered into as of March 14, 2018 between Akcea Therapeutics Inc., a Delaware corporation (Akcea or the Company), and Ionis Pharmaceuticals, Inc., a Delaware corporation (Ionis or Investor).

Akcea Therapeutics, Inc. – Akcea Therapeutics, Inc. Amended and Restated Investor Rights Agreement (March 15th, 2018)

THIS INVESTOR RIGHTS AGREEMENT (this Agreement) is entered into as of March 14, 2018 between Akcea Therapeutics Inc., a Delaware corporation (Akcea or the Company), and Ionis Pharmaceuticals, Inc., a Delaware corporation (Ionis or Investor).

Everbridge, Inc. – Third Amended and Restated Investor Rights Agreement (March 12th, 2018)

This Amendment to The Third Amended and Restated Investor Rights Agreement (the "Amendment") is effective as of November 20, 2017, by and among Everbridge, Inc., a Delaware corporation (the "Company"), and the undersigned hereto, pursuant to that certain Third Amended and Restated Investor Rights Agreement, dated as of September 9, 2011 (the "Rights Agreement"), by and among the Company and the Investors (as defined therein). Capitalized terms used in this Amendment and not otherwise defined have the meanings ascribed to them in the Rights Agreement.

Iterum Therapeutics Ltd – Iterum Therapeutics Limited Amended and Restated Investor Rights Agreement (February 2nd, 2018)

THIS AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (this Agreement) is entered into as of May 18, 2017, by and among ITERUM THERAPEUTICS LIMITED, a company incorporated under the laws of Ireland (company number 563531) (the Company) and the investors listed on Exhibit A hereto, referred to hereinafter as the Investors and each individually as an Investor, and each of the shareholders listed on Exhibit B hereto, each of whom is referred to herein as a Key Holder All references to $ and dollar herein shall mean United States dollars.

Carbon Black, Inc. – Eighth Amended and Restated Investor Rights Agreement (January 11th, 2018)

THIS EIGHTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the Agreement) is made as of the 30th day of September, 2015, by and among Bit9, Inc., a Delaware corporation (the Company), each of the investors listed on Schedule A hereto (each an Investor and collectively, the Investors, which terms shall also include each person to whom the rights of an Investor are assigned pursuant to Section 6.11 and each person who becomes subject to the provisions hereof pursuant to Section 6.16), each of the key holders listed on Schedule B hereto (each a Key Holder and collectively, the Key Holders, which terms shall also include each person to whom the rights of a Key Holder are assigned pursuant to Section 6.11) and each Carbon Black Stockholder (as defined below).

One Stop Systems Inc – ONE STOP SYSTEMS, INC. SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT January, 2007 (December 18th, 2017)

This Second Amended and Restated Investor Rights Agreement (this Agreement) is made and entered into as of the date set forth above (the Effective Date) by and among One Stop Systems, Inc., a California corporation (the Company), the holders of the Companys Series A Preferred Stock (Series A Preferred) listed on Exhibit A hereto, the holders of the Companys Series B Preferred Stock (Series B Preferred) listed on Exhibit A hereto, the purchasers of the Companys Series C Preferred Stock (Series C Preferred and collectively with the Series A Preferred and Series B Preferred, the Securities) and the individuals listed on Exhibit B hereto (each referred to herein as a Founder and collectively as the Founders). The holders of Series A Preferred and Series B Preferred and the purchasers of Series C Preferred will be referred to herein after as Investors or Purchasers and each individually as Investor or Purchaser. This Agreement will supercede any prior Investor Rights Agreements entered into

One Stop Systems Inc – ONE STOP SYSTEMS, INC. SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT January, 2007 (November 9th, 2017)

This Second Amended and Restated Investor Rights Agreement (this Agreement) is made and entered into as of the date set forth above (the Effective Date) by and among One Stop Systems, Inc., a California corporation (the Company), the holders of the Companys Series A Preferred Stock (Series A Preferred) listed on Exhibit A hereto, the holders of the Companys Series B Preferred Stock (Series B Preferred) listed on Exhibit A hereto, the purchasers of the Companys Series C Preferred Stock (Series C Preferred and collectively with the Series A Preferred and Series B Preferred, the Securities) and the individuals listed on Exhibit B hereto (each referred to herein as a Founder and collectively as the Founders). The holders of Series A Preferred and Series B Preferred and the purchasers of Series C Preferred will be referred to herein after as Investors or Purchasers and each individually as Investor or Purchaser. This Agreement will supercede any prior Investor Rights Agreements entered into

Stitch Fix, Inc. – Stitch Fix, Inc. Fourth Amended and Restated Investor Rights Agreement (October 19th, 2017)

THIS FOURTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the Agreement) is entered into as of April 10, 2014, by and among STITCH FIX, INC., a Delaware corporation (the Company) and the investors listed on Exhibit A (the Investors).

KonaRed Corp – Amended and Restated Investor Rights Agreement (October 5th, 2017)

THIS AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT, dated as of September 29, 2017 (this "Agreement"), is made and entered into by and between KonaRed Corporation, a Nevada corporation (the "Company") and VDF FutureCeuticals, Inc., an Illinois corporation ("Investor").

Roku, Inc – Roku, Inc. Amended and Restated Investor Rights Agreement (September 1st, 2017)

THIS AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the Agreement) is entered into as of the 9th day of November, 2015, by and among Roku, Inc., a Delaware corporation (the Company) and the investors listed on Exhibit A hereto, referred to hereinafter as the Investors and each individually as an Investor.

Roku, Inc – Roku, Inc. Amendment to Amended and Restated Investor Rights Agreement (September 1st, 2017)

This Amendment to that certain AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the Amendment) dated as of November 9, 2015 (the Rights Agreement) is made as of March 6, 2017 by and among ROKU, INC., a Delaware corporation (the Company) and the Investors set forth on Exhibit A of the Rights Agreement (the Investors). Capitalized terms used and not defined herein shall have the definitions ascribed to them in the Rights Agreement.

Roku, Inc – Roku, Inc. Amended and Restated Investor Rights Agreement (July 17th, 2017)

THIS AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the Agreement) is entered into as of the 9th day of November, 2015, by and among Roku, Inc., a Delaware corporation (the Company) and the investors listed on Exhibit A hereto, referred to hereinafter as the Investors and each individually as an Investor.

Roku, Inc – Roku, Inc. Amendment to Amended and Restated Investor Rights Agreement (July 17th, 2017)

This Amendment to that certain AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the Amendment) dated as of November 9, 2015 (the Rights Agreement) is made as of March 6, 2017 by and among ROKU, INC., a Delaware corporation (the Company) and the Investors set forth on Exhibit A of the Rights Agreement (the Investors). Capitalized terms used and not defined herein shall have the definitions ascribed to them in the Rights Agreement.